Merck unveils new cyber-physical trust platform at CES 2025
7th January 2025 Uncategorised 0M-Trust set to improve product safety and counterfeiting solutions More: Merck unveils new cyber-physical trust platform at CES 2025 Source: News
read more
M-Trust set to improve product safety and counterfeiting solutions More: Merck unveils new cyber-physical trust platform at CES 2025 Source: News
read moreGlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect launches of medicines including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy to help add $20 billion to the value of
read moreWith COVID vaccine sales in the doldrums and an RSV vaccine market in “contraction”, Moderna CEO Stéphane Bancel had the unenviable task of trying to put a positive spin on a sharp stock decline in his annual shareholder letter. More:
read moreFor the second year in a row, Bausch + Lomb has joined with the Glaucoma Research Foundation to launch the “Faces of Glaucoma” campaign during January’s Glaucoma Awareness Month. More: Bausch + Lomb re-ups 'Faces of Glaucoma' campaign to raise
read moreFollowing Viatris’ December announcement that a manufacturing plant in India had been written up by the FDA, a document published by the U.S. regulator reveals the details behind the company’s manufacturing infractions. More: FDA warning letter reveals quality control, data
read moreIn a draft guidance document, the FDA specified criteria to determine whether a confirmatory trial is “underway” prior to an accelerated approval. More: FDA looks to clarify confirmatory trial mandate for accelerated approvals Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals